SUMMARY Cytogenetic studies on a mentally retarded boy revealed an X-Y translocation, karyotype 46,X,t(X;Y)(p22;ql 1). Only 5 other such cases have been reported and these were all females. The unequivocal male phenotype suggested non-random inactivation of the normal maternally derived X chromosome, and that the non-inactivated X-Y translocation chromosome included the locus for male determination. Confirmation of this was provided by unassociated X and Y chromatin in interphase cells, as well as by reverse banding after BrdU incorporation and autoradiography of metaphase chromosomes. There was anomalous Xg blood group inheritance in the proband, indicating possible localisation of the Xg locus to the terminal portion of the X short arm. Linkage of Xg and a form of X-linked mental retardation is suggested. Close linkage of the Xg locus with the loci for aPgalactosidase, phosphoglycerate kinase, G-6-PD, and MPS II was excluded.Cytologically identifiable translocation of the Y chromosome to the X chromosome has been reported very rarely (Khudr et al., 1973;Borgaonkar et al., 1974; Van den Berghe et al., 1977). In all instances where there was no free-lying Y chromosome, the patients were phenotypic females. Two XX males with presumptive morphological evidence of a Y to X translocation have also been documented (Madan and Walker, 1974;Wachtel et al., 1976).We wish to report the investigation of a mentally retarded child with a morphologically identified X-Y translocation and an unequivocally male phenotype. This patient afforded a valuable opportunity for studying the pattern of X inactivation in such cases, as well as the location of the male determining genes of the Y chromosome, and the linkage of genes possibly located on the distal portion of the short arm of the X chromosome, including the Xg locus.
Case reportThe proband was first referred at the age of 4 years for investigation of severe mental retardation associated
Background: Myofascial Reorganization (MFR) is a physiotherapy technique that mixes myofascial pressures and slips and has been used as a simple and non-invasive method that readjusts soft tissues, as well as myofascial adhesions and contractures that may cause decreased blood supply and consequently of physical activity. Objective: To verify if the MFR alters the tissue oxygenation of the trapezius muscle (TM) in subjects without the pain symptom in the evaluation day. Methods: The sample consisted of eight subjects with a mean age of 23 (± 6) years and a body mass index of 23.2 (±15.0) kg.m-2. Changes in muscle oxygenation were measured by near infrared spectroscopy (NIRS) (Portamon, Artinis, the Netherlands) in TM before and after 15 minutes of intervention. The proposed MFR protocol lasted approximately 10 minutes and consisted of pressures, stretching and myofascial slippage of the upper, middle and lower TM fibers. Data normality was performed using the Shapiro Wilk test and due to the parametric nature of the data, the paired t-test was used for pre and post intervention comparison. Results: There was a significant increase in the tissue saturation index (TSI) in the trapezius muscle (80.7±2.7% vs. 89.4±4.6%; p= 0.002) in the pre and post intervention comparison. The pre-post variation delta of oxyhemoglobin - O2 Hb (8.1±11.2 g/dL), deoxyhemoglobin - HHb (-0.72±1.6 g/dL) and total hemoglobin - tHB (7.4±12.3 g/dL) showed no significant difference. However, there was an increase in O2 Hb, tHB levels and a decrease in HHb. Conclusion: The findings showed that the MFR applied on trapezius muscle increased the TSI, which reflects on peripheral muscle oxygenation in subjects without pain in the day of evaluation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.